People Before Profits: A COVID-19 Clarion Call
In 2001, the World Trade Organization (WTO) confronted the impact of intellectual property (IP) obligations enshrined in its multilateral agreement, the TRIPS Agreement, on global attempts to address the HIV pandemic. At the time, multinational pharma companies sued South African President Nelson Mandela over legal provisions to allow the import of affordable generic HIV treatment; these companies, as patent holders on the treatments...